Ogivri

Indicated For

breast cancer, stomach cancer

About This Medication

# Biocon Biologics Patient Assistance Program Patient Guide: How to Get Ogivri (trastuzumab-dkst) at Low or No Cost Ogivri (trastuzumab-dkst) is a biosimilar to Herceptin used to treat certain types of breast cancer and gastric cancer by targeting the HER2 protein on cancer cells. The **Biocon Biologics Patient Assistance Program** helps eligible patients access Ogivri at low or no cost if they face financial hardship or insurance challenges.[3] ## About Ogivri (trastuzumab-dkst) **Ogivri** is an intravenous biosimilar medication approved by the FDA for the same indications as Herceptin (trastuzumab), including adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer. It works by binding to HER2 receptors, inhibiting cancer cell growth. Administered in a clinical setting, typical dosing starts with a loading dose of 8 mg/kg followed by 6 mg/kg every 3 weeks. Always follow your doctor's prescription, as treatment plans vary based on your condition, weight, and response.[3] This guide focuses on the **Biocon Biologics Patient Assistance Program**, which provides support services like benefits verification, prior authorization help, copay assistance, and potential free medication for uninsured or underinsured patients. Note that specific details like income limits are not publicly detailed; eligibility is determined case-by-case.[1][2][3][4] ## Who Qualifies? The program is designed for U.S. residents (including Puerto Rico) facing barriers to affording Ogivri. While exact criteria like income thresholds are not specified in available materials, programs like this typically target: - Patients with limited or no prescription coverage. - Those with high out-of-pocket costs after insurance. - Financially needy individuals, often at or below certain federal poverty levels (FPL), though no specific FPL percentage (e.g., 400% or 500%) is listed. **Income Eligibility Breakdown** | Household Size | Annual Income Threshold | Notes | |---------------|-------------------------|-------| | Individual | Not specified | Case-by-case review; call for details[3] | | Couple | Not specified | May consider total household income[3] | | Family of 3 | Not specified | Proof of income often required[5] | | Family of 4 | Not specified | Adjustments for larger families possible[5] | Contact the program at **(833) 695-2623** (Monday-Friday, 9am-8pm ET) for personalized eligibility assessment, as thresholds may align with FPL guidelines common in pharma PAPs (e.g., up to 400-500% FPL, but confirm directly).[3] ## Insurance Requirements Insurance details are **required** on the application, including medical and pharmacy benefit cards (front and back). The program supports commercially insured patients via copay assistance but excludes those on government programs like Medicare, Medicaid, or similar if they restrict copay adjustments.[1][2][4] Uninsured patients or those with no coverage qualify for full assistance. Services include prior authorization (PA) support—submit clinical info with your prescription. Fax both sides of insurance cards.[1][2] ## Step-by-Step Application Process The program offers **multiple application methods** for flexibility:[3] 1. **Download the Form**: Get the Patient Enrollment Form from the provider portal.[3] 2. **Complete Sections**: - **Patient Info**: Full name, DOB, address, phone, email, gender.[1][2] - **Insurance Info**: Cardholder name, group ID, policy/member ID, BIN/PCN.[1][2] - **Prescription Info**: ICD-10 code, dosing (e.g., IV induction), services requested (BV, PA, copay).[1] - **Prescriber Info**: Doctor's name, NPI, signature, contact details.[1][2] 3. **Gather Documents**: Insurance cards, proof of income (if requested), prescription (attach official state form if no eRx, e.g., NY ONYSRX).[1][2] 4. **Submit**: - **Fax**: To 833-247-2756 or 1-833-726-4848 (per product forms).[1][2][3] - **Phone Assistance**: Call (833) 695-2623 for help or e-prescription guidance.[3] - **E-Prescription**: Send directly via EHR to Biocon's pharmacy network.[1][2] 5. **Follow Up**: Expect patient access specialist support for benefits verification and appeals.[1] Your doctor or office staff typically handles submission. Patients under 18 need parent/guardian authorization.[4] ## Timeline and Delivery Processing time varies; copay reimbursements take **6-8 weeks** after submission with receipts.[4] Medication delivery is via specialty pharmacy or clinic infusion—details provided post-approval. Quick Start/Bridge programs may offer interim supply while insurance processes.[1] Call for status updates.[3] ## Alternatives if Denied or Ineligible - **Biosimilar Alternatives**: Herceptin (reference product).[Provided] - **Copay Program**: If commercially insured, enroll separately for out-of-pocket reduction (up to program limits).[4] - **Other PAPs**: Check RxAssist.org for similar programs or manufacturer sites like Boehringer Cares.[5][6] - **State Assistance**: Explore Medicaid, patient foundations (e.g., CancerCare), or 340B clinics. - **Appeal**: Request PA/appeal support from Biocon specialists.[1] ## Disclaimer This guide is for informational purposes based on available program documents as of latest updates. Biocon Biologics reserves the right to change, amend, or end the program without notice. Eligibility is not guaranteed; contact (833) 695-2623 for current details. Consult your healthcare provider before starting treatment. Not legal/financial advice. Program excludes government-insured patients where prohibited.[1][2][3][4]

Program information last verified: March 30, 2026